Patents by Inventor Robin GASIOROWSKI

Robin GASIOROWSKI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-CD300F antibody and uses thereof
    Patent number: 11987625
    Abstract: The present disclosure relates to an isolated antibody, or antigen binding fragment thereof, which specifically binds to an extracellular domain of cd300f, wherein the antibody, or antigen binding fragment thereof, comprises a heavy chain variable region which comprises: (a) an amino acid sequence that is at least 70% identical to the amino acid sequence represented by seq id no: 1; and/or (b) a complementarity determining region 1 (cdr1) that comprises the amino acid sequence represented by seq id no: 2, a complementarity determining region 2 (cdr2) that comprises an amino acid sequence that is represented by seq id no: 3, and/or a complementarity determining region 3 (cdr3) that comprises an amino acid sequence that is represented by seq id no: 4, compositions comprising the antibody, antigen binding fragment thereof, and uses for therapy.
    Type: Grant
    Filed: November 22, 2017
    Date of Patent: May 21, 2024
    Assignee: DENDROCYTE BIOTECH PTY LTD
    Inventors: Derek Nigel John Hart, Georgina Jane Clark, Robin Gasiorowski
  • ANTI-CD300F ANTIBODY AND USES THEREOF
    Publication number: 20230063312
    Abstract: The present disclosure relates to an isolated antibody, or antigen binding fragment thereof, which specifically binds to an extracellular domain of cd300f, wherein the antibody, or antigen binding fragment thereof, comprises a heavy chain variable region which comprises: (a) an amino acid sequence that is at least 70% identical to the amino acid sequence represented by seq id no: 1; and/or (b) a complementarity determining region 1 (cdr1) that comprises the amino acid sequence represented by seq id no: 2, a complementarity determining region 2 (cdr2) that comprises an amino acid sequence that is represented by seq id no: 3, and/or a complementarity determining region 3 (cdr3) that comprises an amino acid sequence that is represented by seq id no: 4, compositions comprising the antibody, antigen binding fragment thereof, and uses for therapy.
    Type: Application
    Filed: November 22, 2017
    Publication date: March 2, 2023
    Applicant: DENDROCYTE BIOTECH PTY LTD
    Inventors: Derek Nigel John HART, Georgina Jane CLARK, Robin GASIOROWSKI